No Data
No Data
Those Who Invested in MediWound (NASDAQ:MDWD) Five Years Ago Are up 30%
MediWound | 6-K: Report of foreign private issuer (related to financial reporting)
Optimistic Buy Rating for Mediwound: Strong Financials and Strategic Growth Initiatives Highlight Promising Future
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25
Craig-Hallum Maintains MediWound(MDWD.US) With Buy Rating, Announces Target Price $39
Mediwound (MDWD) Receives a New Rating From Craig-Hallum